Are dependent on opioid pain medications, taking medications to help stop opioids, or experiencing opioid withdrawal
Common adverse effectsnausea, vomiting, diarrheatypically diminish with gradual dose titration
Plus, says Vash, when you go to the bathroom, the medication causes an oily discharge. (Thats the fat your body isnt absorbing.) And, he says, orlistat results in an average 6% weight loss, which is much lower than other weight-loss medications
Comorbidities: Type 2 diabetes: Both are FDA-approved for diabetes (tirzepatide as Mounjaro, semaglutide as Ozempic) Cardiovascular disease: Semaglutide has the cardiovascular outcomes data Sleep apnea: Tirzepatide has shown benefits Injection frequency: Both are once-weekly